These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 9216841

  • 1. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C, Pons JF, Duchesne MJ, Auzou G, Pons M, Nique F, Teutsch G, Borgna JL.
    J Med Chem; 1997 Jul 04; 40(14):2217-27. PubMed ID: 9216841
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS, Parker CJ, McCague R, Jordan VC.
    Mol Pharmacol; 1991 Mar 04; 39(3):421-8. PubMed ID: 2005879
    [Abstract] [Full Text] [Related]

  • 3. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
    Connor K, Ramamoorthy K, Moore M, Mustain M, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P.
    Toxicol Appl Pharmacol; 1997 Jul 04; 145(1):111-23. PubMed ID: 9221830
    [Abstract] [Full Text] [Related]

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov 04; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 5. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS.
    Cancer Res; 1985 Sep 04; 45(9):4192-9. PubMed ID: 4040807
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
    Labaree DC, Zhang JX, Harris HA, O'Connor C, Reynolds TY, Hochberg RB.
    J Med Chem; 2003 May 08; 46(10):1886-904. PubMed ID: 12723952
    [Abstract] [Full Text] [Related]

  • 7. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA.
    Cancer Res; 1984 Jun 08; 44(6):2302-8. PubMed ID: 6547074
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
    Freyberger A, Schmuck G.
    Toxicol Lett; 2005 Jan 15; 155(1):1-13. PubMed ID: 15585354
    [Abstract] [Full Text] [Related]

  • 11. Steroidal affinity labels of the estrogen receptor alpha. 4. Electrophilic 11beta-aryl derivatives of estradiol.
    Aliau S, Delettre G, Mattras H, El Garrouj D, Nique F, Teutsch G, Borgna JL.
    J Med Chem; 2000 Feb 24; 43(4):613-28. PubMed ID: 10691688
    [Abstract] [Full Text] [Related]

  • 12. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
    Wiese TE, Polin LA, Palomino E, Brooks SC.
    J Med Chem; 1997 Oct 24; 40(22):3659-69. PubMed ID: 9357533
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
    Erber S, Ringshandl R, von Angerer E.
    Anticancer Drug Des; 1991 Nov 24; 6(5):417-26. PubMed ID: 1764164
    [Abstract] [Full Text] [Related]

  • 15. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
    Wilson VS, Bobseine K, Gray LE.
    Toxicol Sci; 2004 Sep 24; 81(1):69-77. PubMed ID: 15166400
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S, Vessières A, Leclercq G, Quivy J, Tang J, Vaissermann J, Huché M, Jaouen G.
    Chemistry; 2003 Nov 07; 9(21):5223-36. PubMed ID: 14613131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C, Hollander C, Miller B.
    Cancer Res; 1986 May 07; 46(5):2276-81. PubMed ID: 3697973
    [Abstract] [Full Text] [Related]

  • 20. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
    Borgna JL, Scali J.
    Eur J Biochem; 1991 Aug 01; 199(3):575-85. PubMed ID: 1868844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.